Monbretin A (MbA) synthesis using a heterologous nucleic acid(s) encoding A MbA pathway enzyme

Patent metadata

Field	Value
Publication number	US-12454714-B2
Application number	US-201917254461-A
Country	US
Kind code	B2
Filing date	Jun 21, 2019
Priority date	Jun 22, 2018
Publication date	Oct 28, 2025
Grant date	Oct 28, 2025

Abstract

Provided are transgenic organisms, such as plants and plant parts, cells, and related compositions and methods for producing and monitoring the genotype for enhanced production of montbretin A and/or its precursors. For example, provided is a transgenic organism comprising at least one heterologous nucleic acid operatively linked to a promoter, wherein the heterologous nucleic acid encodes at least one enzyme in a montbretin A (MbA) metabolic pathway. The organisms can be a plant, plant part, or plant cell, or a microorganism such as a yeast. Also provided is a method for producing at least one montbretin A (MbA) precursor and/or MbA, comprising permitting the expression of the at least one heterologous nucleic acid in the transgenic organism. The disclosure also provides isolated nucleic acid molecules that comprise sequence encoding at least one enzyme in a montbretin A (MbA) metabolic pathway and vectors comprising the nucleic acids.

First claim

The invention claimed is:

1. A transgenic organism comprising at least one heterologous nucleic acid operatively linked to a promoter, wherein the heterologous nucleic acid encodes at least one enzyme in a montbretin A (MbA) metabolic pathway;
wherein the transgenic organism produces montbretin A (MbA) and/or at least one precursor thereof, wherein the MbA precursor is selected from naringenin, dihydrokaempferol (DHK), kaempferol, eriodictyol, dihydroquercetin (DHQ), quercetin, pentahydroxyflavanon (PHF), dihydromyricetin (DHM), myricetin, myricetin 3-O-rhamnoside (MR), myricetin 3-O-glycosyl rhamnoside (MRG), myricetin 3-O-(6′ O-caffeoyl)-glucosyl rhamnoside (mini MbA), myricetin 3-O-(glucosyl-6′-O-caffeoyl)-glucosyl rhamnoside (MbA-XR 2 ), and myricetin 3-O-(glucosyl-6′-O-caffeoyl)-glucosyl rhamnoside 4′-O-xyloside (MbA-R 2 );
wherein the at least one enzyme in the MbA metabolic pathway is selected from a flavanone hydroxylase (F3H), flavonol synthase (FLS), a flavonoid 3′-hydroxylase (F3′H), a flavonoid 3′5′-hydroxylase (F3′5′H), a UDP sugar dependent glycosyltransferase (UGT), and a BAHD-acyltransferase (BAHD-AT); or wherein the transgenic organism comprises a plurality of heterologous nucleic acids operatively linked to one or more promoters, wherein each of the plurality of heterologous nucleic acids encodes at least one enzyme in a MbA metabolic pathway independently selected from a F3′H, FLS, F3′H, a F3′5′H, a UGT, and a BAHD-AT in any combination; and
wherein the at least one enzyme comprises one of the following:
a F3H, wherein the F3H has an amino acid sequence with at least 85% identity to the amino acid sequence set forth in SEQ ID NO:2 or SEQ ID NO:4;
a FLS, wherein the FLS has an amino acid sequence with at least 85% identity to the amino acid sequence set forth in SEQ ID NO:6;
a F3′H, wherein the F3′H has an amino acid sequence with at least 85% identity to the amino acid sequence set forth in SEQ ID NO:8;
a F3′5′H, wherein the F3′5′H has an amino acid sequence with at least 85% identity to the amino acid sequence set forth in SEQ ID NO:10;
a BAHD-AT, wherein the BAHD-AT has an amino acid sequence with at least 85% identity to the amino acid sequence set forth in SEQ ID NO: 16 or SEQ ID NO: 18;
a UGT, wherein the UGT has an amino acid sequence with at least 85% identity to the amino acid sequence set forth in SEQ ID NO:12 or SEQ ID NO:14 or SEQ ID NO:20 or SEQ ID NO: 22 or SEQ ID NO:24.

2. The transgenic organism of claim 1 , wherein the transgenic organism is a plant, plant part, plant cell or a microorganism.

3. The transgenic organism of claim 1 , wherein the transgenic organism is a plant, plant part, or plant cell that produces an elevated amount of MbA and/or at least one precursor thereof compared to a plant, plant part, or plant cell of the same species under equivalent conditions but that does not comprise the heterologous nucleic acid.

4. The transgenic organism of claim 1 , wherein the heterologous nucleic acid encoding the at least one enzyme is from a montbretia ( Crocosmia ) plant.

5. The transgenic organism of claim 1 , wherein the at least one enzyme comprises one of the following:
a F3H, wherein the F3H is selected from CcF3H1 from a montbretia ( Crocosmia x crocosmiiflora ) plant, CcF3H2 from a montbretia ( Crocosmia x crocosmiiflora ) plant, or a homolog thereof;
a FLS, wherein the FLS is CcFLS from a montbretia ( Crocosmia x crocosmiiflora ) plant, or a homolog thereof;
a F3′H, wherein the F3′H is CcYP1 from a montbretia ( Crocosmia x crocosmiiflora ) plant, or a homolog thereof;
a F3′5′H, wherein the F3′5′H is CcYP2 from a montbretia ( Crocosmia x crocosmiiflora ) plant, or a homolog thereof;
a UGT, wherein the UGT is CcUGT1 from a montbretia ( Crocosmia x crocosmiiflora ) plant, or a homolog thereof;
a UGT, wherein the UGT is CcUGT2 from a montbretia ( Crocosmia x crocosmiiflora ) plant, or a homolog thereof;
a BAHD-AT, wherein the BAHD-AT is selected from CcAT1 from a montbretia ( Crocosmia x crocosmiiflora ) plant, CcAT2 derived from a montbretia ( Crocosmia x crocosmiiflora ) plant, or a homolog thereof;
a UGT, wherein the UGT is CcUGT3 from a montbretia ( Crocosmia x crocosmiiflora ) plant, or a homolog thereof;
a UGT, wherein the UGT is CcUGT4 from a montbretia ( Crocosmia x crocosmiiflora ) plant, or a homolog thereof;
and
a UGT, wherein the UGT is CcUGT5 from a montbretia ( Crocosmia x crocosmiiflora ) plant, or a homolog thereof.

6. The transgenic organism of claim 2 , wherein the plant, plant part, or plant cell is in the genus Nicotiana.

7. The transgenic organism of claim 2 , wherein the plant, plant part, or plant cell is Nicotiana benthamiana or wherein the microorganism is a yeast.

8. A method for producing at least one montbretin A (MbA) precursor, comprising permitting the expression of the at least one heterologous nucleic acid in the transgenic organism of claim 1 .

9. The method of claim 8 , further comprising providing the transgenic organism with a sufficient source of myricetin.

10. The method of claim 8 , further extracting the at least one MbA precursor from the transgenic organism.

11. The method of claim 8 , wherein the transgenic organism produces MbA from the at least one precursor.

12. The method of claim 11 , wherein the transgenic organism comprises a plurality of heterologous nucleic acids operatively linked to one or more promoters, wherein each of the plurality of heterologous nucleic acids encodes a different enzyme in the montbretin A (MbA) metabolic pathway, wherein the different enzymes are selected from a flavanone hydroxylase (F3H), flavonol synthase (FLS), a flavonoid 3′-hydroxylase (F3′H), a flavonoid 3′5′-hydroxylase (F3′5′H), and a UDP-sugar dependent glycosyltransferase (UGT), and a BAHD-acyltransferase (BAHD-AT) in any combination.

13. The method of claim 11 , further extracting the MbA from the transgenic organism.

Assignees

• Univ British Columbia

Inventors

• Bohlmann Carl Joerg
• Irmisch Sandra
• Jo Seohyun

Classifications

• C12Y114/11023

  Flavonol synthase (1.14.11.23) · CPC title

• C12Y114/11009

  Flavanone 3-dioxygenase (1.14.11.9), i.e. naringenin-3-dioxygenase · CPC title

• C12Y114/11

  with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11) · CPC title

• C12N15/825

  involving pigment biosynthesis · CPC title

• C12N9/1051

  Hexosyltransferases (2.4.1) · CPC title